This site uses cookies. By using this site you agree to receiving cookies. View Policy.

319%

Accexible aims to help the ⅔ of people with mild cognitive impairment who traditionally miss dementia diagnosis. Their patent-pending platform has >93% accuracy & is currently being tested by a Spanish NHS Hospital. Raising funds to accelerate their mission to better the lives of the 10m+ people diagnosed each year.

  • More than 93% accuracy, reducing time to diagnose by half
  • Spanish NHS is testing Accexible as a screening dementia tool in one hospital
  • Secured contract with the Neurology Unit at Quiron Hospital
  • 500k+ raised capital including a prestigious Spanish NEOTEC grant

Idea

Someone in the world develops dementia every 3 seconds. Seeing the global epidemic of dementia increasing, with 50m cases globally and 10m new cases annually, we knew we could create something better than the paper-based screening tests currently used for diagnosis.

Since launching Accexible in 2017, our aim has been to enable earlier diagnosis and action to help the 2/3 of people with mild cognitive impairment who are not diagnosed, 38% of whom will develop dementia in 5 years. Missing earlier diagnosis also limits the effectiveness of treatment.

We have developed a platform that detects and monitors dementia through speech analysis using AI algorithms of standardized tests. These tests, which can be done on any device with an internet connection and a microphone, can detect early dementia with >93% accuracy in minutes.

The platform has performed over 3000 neuropsychological tests and has been tested in different environments, including primary care and telehealth services. It has received its CE marking and is patent-pending, and we are in conversations to build partnerships with telemedicine providers to roll out in a B2C model.

In 2021 we aim to go to the US Market (FDA) with our competitive advantage of higher accuracy rates. Funds from this round will also help us to accelerate time to market in the EU.

Join us on our mission to digitise the world of dementia diagnosis.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the acceXible pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered?
Log in

Risk warning

Investments of this nature carry risks to your capital, including illiquidity, lack of dividends and dilution. Balance risk with a diversified portfolio. Read more. Approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.